These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10427)

  • 61. Synthesis and pharmacological investigations of 1,2,3,4-tetrahydroisoquinoline derivatives.
    Brzezinska E; Venter D; Glinka R
    Pharmazie; 1996 Jun; 51(6):397-9. PubMed ID: 8767849
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A potent new beta2-adrenoceptor blocking agent.
    Imbs JL; Miesch F; Schwartz J; Velly J; Leclerc G; Mann A; Wermuth CG
    Br J Pharmacol; 1977 Jul; 60(3):357-62. PubMed ID: 19116
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inotropic beta-blocking potency (pA2) and partial agonist activity of propranolol, practolol, sotalol and acebutolol.
    Lewis MJ; Grey AC; Henderson AH
    Eur J Pharmacol; 1982 Dec; 86(1):71-6. PubMed ID: 6130956
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of atenolol, metroprolol, and pamatolol on cardiac and vascular beta-adrenoceptors in the rat.
    Johansson B
    J Cardiovasc Pharmacol; 1979; 1(3):287-98. PubMed ID: 94397
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
    Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
    J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The action of sympathomimetic amines and a new beta-adrenergic blocking agent (4-(2-hydroxy-3-isopropylaminopropoxy)-indole) on the isolated trachea of guinea pigs.
    Otorii T
    Jpn J Pharmacol; 1969 Dec; 19(4):597-603. PubMed ID: 4391523
    [No Abstract]   [Full Text] [Related]  

  • 67. Effects of bunitrolol on adrenergic and serotonergic receptors.
    Tsuchihashi H; Aono J; Nagatomo T; Kawada T; Ohta H; Imai S
    Jpn J Pharmacol; 1987 Nov; 45(3):349-56. PubMed ID: 2893855
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Studies on the mode of antagonism between adrenergic beta-mimetics and beta-blocking agents (II). Analysis by the uptake saturation model.
    Ohashi M; Iwasawa Y; Kiyomoto A
    Jpn J Pharmacol; 1976 Feb; (1):79-90. PubMed ID: 4640
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MY336-a, a novel beta-adrenergic receptor antagonist produced by Streptomyces gabonae.
    Kase H; Fujita H; Nakamura J; Hashizume K; Goto J; Kubo K; Shuto K
    J Antibiot (Tokyo); 1986 Mar; 39(3):354-63. PubMed ID: 2871004
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function.
    Beumer HM
    Drugs; 1974; 7(1):130-8. PubMed ID: 4151697
    [No Abstract]   [Full Text] [Related]  

  • 71. 2-Benzodioxinylaminoethanols: a new class of beta-adrenergic blocking and antihypertensive agents.
    Lalloz L; Loppinet V; Coudert G; Guillaumet G; Loubinoux B; Labrid C; Beaughard M; Dureng G; Lamar JC
    J Med Chem; 1981 Aug; 24(8):994-8. PubMed ID: 6120237
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Negative inotropic effects and the hydrophobicity of beta-adrenergic blocking agents.
    Harada S; Ban T; Fujita T; Koshiro A
    Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):262-71. PubMed ID: 6118107
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mode of antagonism between beta-adrenergic drugs and prostaglandin F2-alpha.
    Offermeier J; Brandt HD
    S Afr Med J; 1974 Oct; 0(0):Suppl:36-9. PubMed ID: 4153557
    [No Abstract]   [Full Text] [Related]  

  • 74. An analysis of the B-adrenergic action of oxyfedrine.
    Sakai K; Shiraki Y; Hashimoto K
    Eur J Pharmacol; 1973 Jan; 21(1):81-8. PubMed ID: 4145385
    [No Abstract]   [Full Text] [Related]  

  • 75. Analysis of the beta-receptor mediated effect on fast-contracting skeletal muscle in vitro.
    Holmberg E; Waldeck B
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):109-13. PubMed ID: 23500
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alpha-1 and beta-adrenergic receptor blocking potencies of bopindolol and its two metabolites (18-502 and 20-785) as assessed by radioligand binding assay methods.
    Hosohata Y; Sasaki K; Suzuki M; Karakisawa Y; Maruyama K; Tsuchihashi H; Nagatomo T
    Gen Pharmacol; 1995 Jul; 26(4):743-7. PubMed ID: 7635249
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of temperature on the sensitivity of the -receptors and the contractility of guinea-pig atrium.
    Reinhardt D; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(1):95-104. PubMed ID: 4404649
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharmacological approaches to the characterization of beta-adrenoreceptor populations in tissues.
    O'Donnell SR; Wanstall JC
    J Auton Pharmacol; 1981 Sep; 1(4):305-12. PubMed ID: 6121816
    [No Abstract]   [Full Text] [Related]  

  • 79. The beta-adrenergic responses in isolated splenic capsule area of several species of animals.
    Takasaki K; Tang LC; Urabe M
    Jpn J Pharmacol; 1979 Feb; 29(1):1-7. PubMed ID: 222923
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A trial for kinetic evaluation of the antagonistic potency of several beta-antagonists on presynaptic beta-adrenoceptors.
    Kuwahara M; Amano H; Kubo T; Misu Y
    Jpn J Pharmacol; 1987 Apr; 43(4):445-8. PubMed ID: 2886690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.